Case reports highlight stent removal after effective chemoradiotherapy and durvalumab in NSCLC patients with airway stenosis, suggesting improved outcomes.
Airway stents improve respiratory conditions and Eastern Cooperative Oncology Group Performance Status scores in cases of airway stenosis, as observed in patients with stage III non-small cell lung cancer (NSCLC) who experience prolonged survival after undergoing chemoradiotherapy followed by durvalumab treatment. Herein, we report three cases of severe airway stenosis due to stage III NSCLC in patients who underwent airway stenting and subsequent stent removal after chemoradiotherapy and durvalumab administration. The number of stents removed will likely increase in the future due to the high response rates to molecular drugs and immune checkpoint inhibitors.
No takes yet. Share an insight, caveat, or question.
Takigawa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: